XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Om of Medicine
Share Capital
Share Capital
Om of Medicine
Additional Paid-In Capital
Deficit
Total 4Front Ventures Corp. Shareholders' Equity
Total 4Front Ventures Corp. Shareholders' Equity
Om of Medicine
Non-Controlling Interest
Beginning Balance at Dec. 31, 2020 $ 42,203   $ 250,583   $ 42,116 $ (250,548) $ 42,151   $ 52
Beginning Balance, Shares at Dec. 31, 2020 538,851,252   538,851,252            
Shares issued for Pure Ratios earnout $ 161   $ 161       161    
Shares issued for Pure Ratios earnout, shares     473,491            
Share-based compensation 2,396       2,396   2,396    
Conversion of notes to equity 6,253   $ 6,253       6,253    
Conversion of notes to equity, shares     24,366,003            
Shares issued with exercise of stock options 871   $ 871       871    
Shares issued with exercise of stock options, shares     1,358,116            
Shares issued with exercise of warrants 1,563   $ 1,563       1,563    
Shares issued with exercise of warrants, shares     2,422,363            
Return of treasury shares     (8,320)            
Net loss (11,084)   $ 0   0 (11,089) (11,089)   5
Ending Balance at Mar. 31, 2021 42,363   $ 259,431   44,512 (261,637) 42,306   57
Ending Balance, Shares at Mar. 31, 2021     567,462,905            
Beginning Balance at Dec. 31, 2020 $ 42,203   $ 250,583   42,116 (250,548) 42,151   52
Beginning Balance, Shares at Dec. 31, 2020 538,851,252   538,851,252            
Net loss $ (17,302)                
Ending Balance at Jun. 30, 2021 53,568   $ 273,875   47,491 (267,860) 53,506   62
Ending Balance, Shares at Jun. 30, 2021     593,898,521            
Beginning Balance at Mar. 31, 2021 42,363   $ 259,431   44,512 (261,637) 42,306   57
Beginning Balance, Shares at Mar. 31, 2021     567,462,905            
Shares issued for Pure Ratios earnout   $ 722   $ 722       $ 722  
Shares issued for Pure Ratios earnout, shares       535,018          
Share-based compensation 2,979       2,979   2,979    
Conversion of notes to equity 11,466   $ 11,466       11,466    
Conversion of notes to equity, shares     24,676,794            
Shares issued with exercise of stock options 443   $ 443       443    
Shares issued with exercise of stock options, shares     652,940            
Shares issued with exercise of warrants 1,813   $ 1,813       1,813    
Shares issued with exercise of warrants, shares     570,864            
Net loss (6,218)         (6,223) (6,223)   5
Ending Balance at Jun. 30, 2021 53,568   $ 273,875   47,491 (267,860) 53,506   62
Ending Balance, Shares at Jun. 30, 2021     593,898,521            
Beginning Balance at Dec. 31, 2021 $ 37,532   $ 274,120   52,197 (288,857) 37,460   72
Beginning Balance, Shares at Dec. 31, 2021 594,181,604   594,181,604            
Share-based compensation $ 1,038       1,038   1,038    
Conversion of notes to equity 3,122   $ 3,122       3,122    
Conversion of notes to equity, shares     6,235,512            
Shares issued with exercise of warrants 50   $ 50       50    
Shares issued with exercise of warrants, shares     88,659            
Shares issued for Island pursuant to acquisition 18,200   $ 18,200       18,200    
Shares issued for Island pursuant to acquisition, shares     28,571,428            
Net loss (5,894)         (5,899) (5,899)   5
Ending Balance at Mar. 31, 2022 54,048   $ 295,492   53,235 (294,756) 53,971   77
Ending Balance, Shares at Mar. 31, 2022     629,077,203            
Beginning Balance at Dec. 31, 2021 $ 37,532   $ 274,120   52,197 (288,857) 37,460   72
Beginning Balance, Shares at Dec. 31, 2021 594,181,604   594,181,604            
Net loss $ (12,440)                
Ending Balance at Jun. 30, 2022 $ 54,902   $ 302,502   53,625 (301,307) 54,820   82
Ending Balance, Shares at Jun. 30, 2022 637,912,894   637,912,894            
Beginning Balance at Mar. 31, 2022 $ 54,048   $ 295,492   53,235 (294,756) 53,971   77
Beginning Balance, Shares at Mar. 31, 2022     629,077,203            
Share-based compensation 390       390   390    
Shares issued with exercise of stock options 33   $ 33       33    
Shares issued with exercise of stock options, shares     51,975            
Shares issued for Island pursuant to acquisition 6,245   $ 6,245       6,245    
Shares issued for Island pursuant to acquisition, shares     8,783,716            
Warrants issued for Island pursuant to acquisition 732   $ 732       732    
Net loss (6,546)         (6,551) (6,551)   5
Ending Balance at Jun. 30, 2022 $ 54,902   $ 302,502   $ 53,625 $ (301,307) $ 54,820   $ 82
Ending Balance, Shares at Jun. 30, 2022 637,912,894   637,912,894